the 4 investment assets aren't even owned by SeD Biomed
their targeted assets...
Target Assets: SeD Biomed proposes to invest in one or more of the following biomedical assets described below and thereafter invest such biomedical assets into Amarantus.
Asset Name Description
1.Flavonoid Compound Composition for treating neurological disorders such as Alzheimer's Disease (Medical Food) 2.Clorinated Myrectin Shuts down kinases linked to cancer 3.Praesidium Natural mosquito repellent 4.Path-way Anti-Pathogenic Solution Broad spectrum antimicrobial compound
SeD Biomed currently has not acquired any of the abovementioned biomedical assets, the acquisition of which is still subject to negotiation, appropriate due diligence and the signing of definitive agreement(s).
News 
Market Data 
Discover 
